Cardinal Health INC 8-K filings

Cardinal Health announced a 6% revenue increase to $63.7 billion for Q4 FY26 and provided FY27 non-GAAP EPS guidance projecting 13-15% growth.

Cardinal Health has entered into a new $4.0 billion unsecured revolving credit agreement, replacing previous facilities and enhancing its financial flexibility.

Cardinal Health announces the appointment of Anita Zielinski as Chief Accounting Officer, effective November 5, 2026, succeeding Mary Scherer.

Cardinal Health reported strong third quarter fiscal year 2026 results, with revenue increasing 11% to $60.9 billion and non-GAAP diluted EPS rising 35% to $3.17, leading the company to raise its full-year outlook.

Cardinal Health announced the retirement of Board Chair Gregory B. Kenny and the appointment of Patricia A. Hemingway Hall, while reaffirming its fiscal 2026 outlook.

Cardinal Health's Senior Vice President and Chief Accounting Officer, Mary Scherer, has announced her intention to retire in February 2027.

Cardinal Health reported robust second-quarter fiscal year 2026 results with significant revenue and earnings growth, leading to an upward revision of its full-year non-GAAP EPS guidance.

Cardinal Health has raised its fiscal year 2026 non-GAAP diluted earnings per share outlook to at least $10.00, driven by accelerating specialty growth and successful navigation of IRA changes.

Cardinal Health, Inc. announced the results of its 2025 Annual Meeting, where shareholders elected 12 directors, approved executive compensation, and ratified Ernst & Young LLP as auditor.

Cardinal Health reported a strong first quarter for fiscal year 2026 with revenue up 22% and non-GAAP EPS up 36%, leading to a raised full-year guidance.

Cardinal Health, Inc. has entered into a new 364-day, $1.0 billion revolving credit agreement to support general corporate purposes and its commercial paper program.

Cardinal Health Funding, LLC and its subsidiaries extended their receivables purchase agreement with several financial institutions, pushing the facility's termination date to September 28, 2028.

Cardinal Health, Inc. completed a public offering of $1 billion in new notes to partially fund its proposed acquisition of Solaris Health.

Cardinal Health, Inc. announced a $1 billion debt offering to partially fund an upcoming acquisition, issuing notes due 2030 and 2035.

Cardinal Health reported strong fourth-quarter and full-year fiscal 2025 results, raising its fiscal year 2026 non-GAAP EPS guidance and announcing the acquisition of Solaris Health.

Cardinal Health announced a significant increase in its fiscal year 2025 earnings guidance, provided robust preliminary fiscal year 2026 outlook, and detailed new long-term financial targets alongside strategic expansions in specialty solutions and distribution network enhancements.

Cardinal Health reported flat revenue but increased profitability in Q3 FY25, driven by strong performance across all operating segments, leading to an increased fiscal year 2025 outlook.

Cardinal Health has elected Robert Musslewhite and Sudhakar Ramakrishna as independent directors, effective March 7, 2025, to enhance its board with expertise in technology, data analytics, and cybersecurity.

Cardinal Health reported a 4% revenue decrease in Q2 FY25, but a 16% increase excluding a large customer contract expiration, leading to an increased full-year earnings outlook.

Cardinal Health updates its fiscal year 2025 non-GAAP EPS guidance to the higher end of its previous range, driven by strong performance in its Pharmaceutical and Specialty Solutions segment.

Cardinal Health has entered into a $1 billion term loan credit agreement to fund its proposed acquisitions of The GI Alliance Holdings, LLC and Advanced Diabetes Supply Group.

Cardinal Health has successfully completed a $2.9 billion offering of senior notes to finance its acquisitions of The GI Alliance Holdings, LLC and Advanced Diabetes Supply Group.

Cardinal Health has successfully priced a $2.9 billion debt offering, issuing notes with varying maturities and interest rates.

Cardinal Health announces the acquisition of a majority stake in GI Alliance and the Advanced Diabetes Supply Group to enhance its specialty and at-home solutions businesses.

Cardinal Health held its 2024 Annual Meeting of Shareholders on November 6, 2024, where shareholders elected ten directors, approved executive compensation on an advisory basis, and ratified the appointment of Ernst & Young LLP as the independent auditor.

Cardinal Health reported a 4% revenue decrease in Q1, but a 15% increase excluding a large contract expiration, leading to an increased full-year earnings outlook.

Cardinal Health has entered into a new $1 billion revolving credit agreement and increased its commercial paper program limit to $3 billion, enhancing its financial flexibility.

Two Cardinal Health board members, Steven K. Barg and Sujatha Chandrasekaran, will not seek re-election at the 2024 annual meeting of shareholders.

Cardinal Health reports a 12% increase in fourth-quarter revenue and raises its fiscal year 2025 non-GAAP EPS guidance, driven by strong performance in key segments.

Cardinal Health reported a strong third quarter with a 9% revenue increase and raised its fiscal year 2024 non-GAAP EPS guidance while also providing a preliminary outlook for fiscal year 2025.